Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2007

Tripos Inks Library Analysis Agreement with Elan

  • Tripos Discovery Research (TDR) will assist Elan Pharmaceuticals in analyzing and enhancing the diversity of its small molecule screening collection.

    TDR will perform computational clustering of key subsets and determine optimal areas for expansion. The company also will provide high-throughput quality control analyses of legacy compounds via mass spectrometry.

    Applying its computational design and therapeutic medicinal chemistry tools, TDR says that it is able to reduce drug discovery timelines by up to 30%.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »